Latest "Novocell, Inc." News Stories

22:34 EDT 21st October 2017 | BioPortfolio

Here are the most relevant search results for "Novocell, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Novocell, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novocell, Inc. for you to read. Along with our medical data and news we also list Novocell, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novocell, Inc. Companies for you to search.

Showing "Novocell" News Articles, all 1

Wednesday 13th September 2017

ViaCyte Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryViaCyte Inc ViaCyte, formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company's pipeline product portfolio includes VC01, which is being developed as a therapy for T1D patients who have minimal to no insulinproducing beta cell function; and PECDirect, for type 1 diabetes patients that ...

Quick Search

News Quicklinks